Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1999
10/20/1999EP0740655B1 Metalloproteinase inhibitors
10/20/1999EP0708651B1 Therapeutic agent
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232456A PDE IV inhibiting 2-cyanoiminoimidazole derivs.
10/20/1999CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999CN1232448A Vitamin D analogues
10/20/1999CN1232447A Hydroxamic acid derivs.
10/20/1999CN1232402A Method and compositions for immunomodulation
10/20/1999CN1232399A Inhibitors of cysteine protease
10/20/1999CN1045778C Novel chemical compounds having P.DE-IV inhibition activity
10/20/1999CN1045777C Tetracyclic derivs. process of preparation and use
10/20/1999CN1045767C Pyrazole derivs, processes for preparation thereof and pharmaceutical composition comprising same
10/19/1999US5969184 Amide compounds
10/19/1999US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils
10/19/1999US5969093 Secreted proteins
10/19/1999US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease
10/19/1999US5968953 For side effect reduction
10/19/1999US5968951 Benzenesulfonamide derivatives as bradykinin antagonists
10/19/1999US5968948 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/19/1999US5968945 Immunotherapeutic agents
10/19/1999US5968944 Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists
10/19/1999US5968934 Treatment of pain, inflammation, migraines, emesis and postherapeutic neuralgia
10/19/1999US5968927 Azepino-indole compounds; treatment of inflammatory, autoimmune and neurodegenerative diseases, prevention of ischemic injury
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968547 Method of providing sustained analgesia with buprenorphine
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968482 Radiation resistant filters for light protection of cosmetics and drugs
10/17/1999CA2269262A1 Substituted tricyclics
10/17/1999CA2269256A1 Substituted tricyclics
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051580A1 Pyrazole inhibitors of cytokine production
10/14/1999WO1999051571A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999WO1999051569A1 Calcilytic compounds
10/14/1999WO1999051273A1 Gelling ophthalmic compositions containing xanthan gum
10/14/1999WO1999051241A1 Calcilytic compounds and method of use
10/14/1999WO1999051213A2 The use of polyamines in the treatment of dermatological symptoms
10/14/1999WO1999051212A2 Device for the transdermal delivery of diclofenac
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999044623A8 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999042075A3 Antibodies against human cd40
10/14/1999CA2327279A1 Calcilytic compounds
10/14/1999CA2327188A1 Calcilytic compounds and method of use
10/14/1999CA2327185A1 Pyrazole inhibitors of cytokine production
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326759A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2325523A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999CA2325400A1 Device for the transdermal delivery of diclofenac
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325007A1 Human galactosyl transferases
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948651A1 Recombinant n-smases and nucleic acids encoding same
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948509A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948353A1 Methods and compositions for immunomodulation
10/13/1999EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
10/13/1999EP0948330A1 Il-8 receptor antagonists
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0783486B1 Novel prostaglandin synthase inhibitors
10/13/1999EP0710233B1 Heteroaryl cycloalkenyl hydroxyureas
10/13/1999EP0695185B1 Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions
10/13/1999EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
10/13/1999CN1231700A Loxoprofen-containing preparation for external use
10/13/1999CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999CN1231203A Ointment for rheumatic spur
10/13/1999CN1231202A Traditional Chinese medicine preparation for treating colitis
10/13/1999CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/13/1999CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/12/1999US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis